Alexandra Prieux, CEO of ALCEDIAG, is graduated from Ecole Centrale Paris and holds an MBA from MIT Sloan School of Management.
After a first career at Ernst&Young and McKinsey & Co, she joined in 2012 the ALCEN group, which brings together high-tech companies in sectors such as Medical and Energy. She was the first Head of development, working on innovative proprietary technologies (thermodynamic solar energy, nanotechnology). In 2016, she became CEO of ALCEDIAG, specializing in the development of blood tests for mental health. Alexandra and her team developed the world’s first clinically validated, CE marked blood test with excellent sensitivity and specificity for the differential diagnosis of bipolar disorder and depression.
Hear me speak at HBI
Opportunities in Mental Health
The world faces a mental health pandemic. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far are more acute...
St James - 4th Floor